Pages that link to "Q42827324"
Jump to navigation
Jump to search
The following pages link to Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis (Q42827324):
Displaying 50 items.
- SCCRO promotes glioma formation and malignant progression in mice (Q24633442) (← links)
- The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo (Q24657924) (← links)
- The use of antisense oligonucleotides in evaluating survivin as a therapeutic target for radiation sensitization in lung cancer (Q24804080) (← links)
- Gene therapy for brain tumors: basic developments and clinical implementation (Q26829086) (← links)
- Lrig2-deficient mice are protected against PDGFB-induced glioma (Q28506352) (← links)
- Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1) (Q28513336) (← links)
- The role of myosin II in glioma invasion of the brain (Q30482874) (← links)
- Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas (Q30505276) (← links)
- Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma (Q30542153) (← links)
- Sustained delivery of a HIF-1 antagonist for ocular neovascularization (Q30560557) (← links)
- Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma (Q33399939) (← links)
- Dynamics of central and peripheral immunomodulation in a murine glioma model (Q33410400) (← links)
- Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma (Q33414998) (← links)
- Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma (Q33521707) (← links)
- BMP signaling induces astrocytic differentiation of clinically derived oligodendroglioma propagating cells (Q33554078) (← links)
- Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas (Q33609232) (← links)
- Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny (Q33703639) (← links)
- Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link? (Q33729734) (← links)
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas (Q33744491) (← links)
- Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas. (Q33753980) (← links)
- Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail? (Q33828102) (← links)
- Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety. (Q33828114) (← links)
- Glioblastoma Models Reveal the Connection between Adult Glial Progenitors and the Proneural Phenotype (Q33916126) (← links)
- Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression (Q33960280) (← links)
- Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma (Q34083282) (← links)
- Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. (Q34159409) (← links)
- Astrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment. (Q34185886) (← links)
- Gliomagenesis and the use of neural stem cells in brain tumor treatment (Q34310698) (← links)
- Maximizing mouse cancer models (Q34661270) (← links)
- Better prognosis of patients with glioma expressing FGF2-dependent PDGFRA irrespective of morphological diagnosis (Q34695556) (← links)
- Glial progenitors as targets for transformation in glioma (Q34735661) (← links)
- An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice (Q34755317) (← links)
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression (Q34993852) (← links)
- Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma (Q35008709) (← links)
- Convection-Enhanced Delivery of Topotecan into a PDGF-Driven Model of Glioblastoma Prolongs Survival and Ablates Both Tumor-Initiating Cells and Recruited Glial Progenitors (Q35040361) (← links)
- Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma. (Q35388292) (← links)
- Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. (Q35440540) (← links)
- Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma (Q35633850) (← links)
- Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma (Q35780214) (← links)
- Safety of recombinant human platelet-derived growth factor-BB in Augment(®) Bone Graft (Q35884670) (← links)
- Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression. (Q35910268) (← links)
- Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity (Q36020891) (← links)
- Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling (Q36065454) (← links)
- Stem cells and brain cancer (Q36144886) (← links)
- Non-germline genetically engineered mouse models for translational cancer research (Q36150711) (← links)
- Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma (Q36213745) (← links)
- Identification of global alteration of translational regulation in glioma in vivo (Q36295318) (← links)
- Convection-enhanced delivery in the treatment of malignant glioma (Q36523379) (← links)
- Platelet-derived growth factor receptor alpha in glioma: a bad seed (Q36528159) (← links)
- Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma (Q36528386) (← links)